Citadel Advisors’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$258K Sell
20,500
-6,600
-24% -$66.9K ﹤0.01% 10827
2025
Q4
$235K Sell
27,100
-46,400
-63% -$403K ﹤0.01% 10689
2025
Q3
$689K Buy
73,500
+33,400
+83% +$311K ﹤0.01% 8368
2025
Q2
$360K Sell
40,100
-18,600
-32% -$148K ﹤0.01% 9388
2025
Q1
$512K Buy
58,700
+50,000
+575% +$503K ﹤0.01% 8423
2024
Q4
$72.5K Sell
8,700
-41,800
-83% -$309K ﹤0.01% 11917
2024
Q3
$299K Sell
50,500
-16,600
-25% -$92.4K ﹤0.01% 9335
2024
Q2
$353K Buy
67,100
+28,500
+74% +$145K ﹤0.01% 8813
2024
Q1
$210K Buy
38,600
+30,900
+401% +$197K ﹤0.01% 10220
2023
Q4
$56.5K Sell
7,700
-2,000
-21% -$13.2K ﹤0.01% 11647
2023
Q3
$79.8K Sell
9,700
-13,400
-58% -$119K ﹤0.01% 11182
2023
Q2
$243K Buy
23,100
+19,300
+508% +$191K ﹤0.01% 9466
2023
Q1
$60.3K Sell
3,800
-2,000
-34% -$34.7K ﹤0.01% 11922
2022
Q4
$109K Buy
+5,800
New +$116K ﹤0.01% 11099
2020
Q4
Sell
-11,200
Closed -$115K 10851
2020
Q3
$115K Sell
11,200
-17,000
-60% -$193K ﹤0.01% 9185
2020
Q2
$308K Buy
28,200
+6,100
+28% +$63K ﹤0.01% 7865
2020
Q1
$170K Sell
22,100
-27,700
-56% -$237K ﹤0.01% 8171
2019
Q4
$493K Sell
49,800
-10,100
-17% -$96.2K ﹤0.01% 6826
2019
Q3
$680K Buy
59,900
+42,000
+235% +$499K ﹤0.01% 6228
2019
Q2
$273K Sell
17,900
-37,300
-68% -$595K ﹤0.01% 7722
2019
Q1
$756K Sell
55,200
-51,900
-48% -$717K ﹤0.01% 6083
2018
Q4
$1.15M Buy
107,100
+13,600
+15% +$185K ﹤0.01% 5090
2018
Q3
$1.65M Buy
93,500
+63,600
+213% +$1.06M ﹤0.01% 4717
2018
Q2
$444K Buy
29,900
+5,400
+22% +$80.5K ﹤0.01% 6562
2018
Q1
$381K Buy
+24,500
New +$409K ﹤0.01% 6343
2017
Q2
Sell
-11,400
Closed -$237K 7405
2017
Q1
$237K Buy
11,400
+1,400
+14% +$30.4K ﹤0.01% 6246
2016
Q4
$224K Buy
+10,000
New +$202K ﹤0.01% 6131
2016
Q2
Sell
-10,900
Closed -$220K 6766
2016
Q1
$220K Sell
10,900
-14,500
-57% -$268K ﹤0.01% 5517
2015
Q4
$437K Buy
25,400
+5,100
+25% +$81.2K ﹤0.01% 4646
2015
Q3
$296K Buy
20,300
+13,200
+186% +$208K ﹤0.01% 5573
2015
Q2
$115K Buy
7,100
+2,000
+39% +$34.3K ﹤0.01% 6949
2015
Q1
$95K Sell
5,100
-4,400
-46% -$93.6K ﹤0.01% 6873
2014
Q4
$207K Sell
9,500
-30,600
-76% -$628K ﹤0.01% 5943
2014
Q3
$823K Buy
40,100
+14,300
+55% +$320K ﹤0.01% 3958
2014
Q2
$582K Buy
25,800
+7,000
+37% +$158K ﹤0.01% 4189
2014
Q1
$459K Buy
18,800
+9,400
+100% +$242K ﹤0.01% 4456
2013
Q4
$254K Buy
9,400
+1,300
+16% +$32.7K ﹤0.01% 4770
2013
Q3
$216K Sell
8,100
-3,100
-28% -$80.4K ﹤0.01% 4690
2013
Q2
$276K Buy
+11,200
New +$248K ﹤0.01% 4372

Other funds holding ADTN

Citadel Advisors's ADTN Position: Q1 2026 in Review

Citadel Advisors increased its Adtran (ADTN) stake by 300% in Q1 2026, buying an estimated $2.99M and bringing the position to 393,734 shares worth $4.95M. The position accounts for ﹤0.01% of the portfolio, ranked #4353.

Citadel Advisors first reported a position in ADTN in Q2 2013 and has held it in 50 quarters since. The position peaked at $85.9M in Q4 2013. 227 funds tracked by Wall St. Rank hold ADTN as of Q1 2026.

  • Citadel Advisors held 393,734 shares of Adtran worth $4.95M as of Q1 2026.
  • Citadel Advisors bought 295,339 Adtran shares in Q1 2026, an estimated $2.99M.
  • Adtran made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4353 holding.
  • Citadel Advisors first reported a position in Adtran in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Adtran position peaked at $85.9M in Q4 2013.
  • 227 funds tracked by Wall St. Rank held Adtran as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.